Increased expression of FGF5 was associated with pancreatic cancer [19], and high FGF5 expression was found in cell lines from renal cell carcinoma (6 of 10) prostate cancer (2 of 3) and breast cancer (1 of 2) [20]. Here, FGF5 is linked to renal cell carcinoma.